1. Home
  2. SONO vs MLTX Comparison

SONO vs MLTX Comparison

Compare SONO & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$15.77

Market Cap

1.8B

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$17.40

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONO
MLTX
Founded
2002
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
SONO
MLTX
Price
$15.77
$17.40
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$19.67
$27.50
AVG Volume (30 Days)
2.2M
1.0M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$1,443,276,000.00
N/A
Revenue This Year
$5.04
N/A
Revenue Next Year
$6.53
N/A
P/E Ratio
$19.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.12
$5.95
52 Week High
$19.82
$62.75

Technical Indicators

Market Signals
Indicator
SONO
MLTX
Relative Strength Index (RSI) 53.88 40.28
Support Level $12.77 $17.00
Resistance Level $17.50 $19.24
Average True Range (ATR) 1.01 0.97
MACD 0.07 -0.21
Stochastic Oscillator 47.72 0.71

Price Performance

Historical Comparison
SONO
MLTX

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: